Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mukti Patel

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Glycobiology|March 26, 2026
Comprehensive analysis of gp120 glycosylation to explore differences between transmitter/founder and chronic HIV-1 isolatesStephen Temesy, Jordan Haly, Yingxue Sun, et al.
Plos Pathogens|May 23, 2025
Transmitted/founder (T/F) HIV-1 derived from sexual contact exhibits greater transmission fitness in human cervical tissue than T/F HIV-1 from blood-to-blood contact: Unique glycan profiles on T/F envelopes associated with transmission phenotypesYiying Zhang, Katja Klein, Annette Ratcliff, et al.
Plos Pathogens|November 18, 2025
Correction: Transmitted/founder (T/F) HIV-1 derived from sexual contact exhibits greater transmission fitness in human cervical tissue than T/F HIV-1 from blood-to-blood contact: Unique glycan profiles on T/F envelopes associated with transmission phenotypesYiying Zhang, Katja Klein, Annette Ratcliff, et al.
Nucleic Acids Research|November 22, 2013
Updates on the web-based VIOLIN vaccine database and analysis systemYongqun He, Rebecca Racz, Samantha Sayers, et al.
JCO Precision Oncology|March 2, 2026
Erratum: Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell TumorsRebecca Hassoun, Reuben Ben-David, John P Sfakianos, et al.
JCO Precision Oncology|September 24, 2025
Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell TumorsRebecca Hassoun, Reuben Ben-David, John P Sfakianos, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Glycobiology|March 26, 2026
Comprehensive analysis of gp120 glycosylation to explore differences between transmitter/founder and chronic HIV-1 isolatesStephen Temesy, Jordan Haly, Yingxue Sun, et al.
Plos Pathogens|May 23, 2025
Transmitted/founder (T/F) HIV-1 derived from sexual contact exhibits greater transmission fitness in human cervical tissue than T/F HIV-1 from blood-to-blood contact: Unique glycan profiles on T/F envelopes associated with transmission phenotypesYiying Zhang, Katja Klein, Annette Ratcliff, et al.
Plos Pathogens|November 18, 2025
Correction: Transmitted/founder (T/F) HIV-1 derived from sexual contact exhibits greater transmission fitness in human cervical tissue than T/F HIV-1 from blood-to-blood contact: Unique glycan profiles on T/F envelopes associated with transmission phenotypesYiying Zhang, Katja Klein, Annette Ratcliff, et al.
Nucleic Acids Research|November 22, 2013
Updates on the web-based VIOLIN vaccine database and analysis systemYongqun He, Rebecca Racz, Samantha Sayers, et al.
JCO Precision Oncology|March 2, 2026
Erratum: Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell TumorsRebecca Hassoun, Reuben Ben-David, John P Sfakianos, et al.
JCO Precision Oncology|September 24, 2025
Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell TumorsRebecca Hassoun, Reuben Ben-David, John P Sfakianos, et al.
Pageof 2